Trials / Completed
CompletedNCT02943655
Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
Combined Oral Contraceptives, Progestogens, and Non-steroidal Anti-inflammatory Drugs for Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Abnormal uterine bleeding encompasses abnormalities in the regularity, duration of flow, frequency, and/or blood flow volume relative to normal menstruation. Of these menstrual abnormalities, heavy menstrual bleeding (HMB), defined objectively as a blood loss of 80 ml or more per menstrual cycle , which is unrelated to pregnancy or known pelvic or systemic disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | combined contraceptive pills (microcept) | oral combined contraceptive once daily |
| DRUG | medroxyprogesterone acetate (progest) | oral 5 mg medroxyprogesterone acetate daily |
| DRUG | mefenamic acid (ponstan forte) | oral 500 mg mefenamic acid three times per day |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2020-10-10
- Completion
- 2021-02-10
- First posted
- 2016-10-25
- Last updated
- 2021-06-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02943655. Inclusion in this directory is not an endorsement.